This compound is an N-protected derivative of L-glutamic acid, featuring a fluorenylmethoxycarbonyl (Fmoc) group and a tert-butyl ester. It is primarily used as a building block in solid-phase peptide synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 84793-07-7
L-Fmoc-Aspartic acid alpha-tert-butyl ester
pharmaceutical intermediate
N²-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-L-α-glutamine
research compound
Trans-4-Dimethylaminocrotonic acid hydrochloride
pharmaceutical intermediate
3-Cyano-7-ethoxy-4-hydroxy-6-(acetylamino)quinoline
pharmaceutical intermediate
N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide
pharmaceutical intermediate
4-{[3-(4-acetylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one
pharmaceutical intermediate
N-(9-Fluorenylmethyloxycarbonyl)-D-glutamic acid 1-tert-butyl ester
research compound
(4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid
GOPWHXPXSPIIQZ-FQEVSTJZSA-N
CC(C)(C)OC(=O)[C@H](CCC(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13